COLOCROSS
Phase 3 Completed
89 enrolled
Palbociclib and Cetuximab in Metastatic Colorectal Cancer
Phase 2 Completed
24 enrolled 14 charts
00-046
Phase 3 Completed
4,952 enrolled
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Phase 1/2 Completed
23 enrolled
Pilot Study of Individualized Comprehensive Rehabilitation in Patients With Colorectal Cancer
Phase NA Completed
150 enrolled
Using Visual Arrays to Support Understanding of Genetic Risk
Phase NA Completed
1,045 enrolled
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
240 enrolled 14 charts
DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease
Phase NA Completed
16 enrolled
Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands
Phase NA Completed
231 enrolled
Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
Phase 1 Completed
52 enrolled
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Completed
42 enrolled
Screen to Save: NCI Colorectal Cancer Outreach & Screening Initiative
Phase NA Completed
188 enrolled
PICoC
Phase 3 Completed
40 enrolled 19 charts
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
Phase 1 Completed
39 enrolled
Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)
Phase NA Completed
46 enrolled 14 charts
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
Phase 2 Completed
78 enrolled 14 charts
Edrecolomab in Treating Patients With Stage II Colon Cancer
Phase 3 Completed
2,100 enrolled
Efficacy and Safety of Supervised Therapeutic Exercise in Cancer Patients With and Without Concurrent Treatment.
Phase NA Completed
78 enrolled
SUCCEED
Phase NA Completed
50 enrolled
Study of Colorectal Cancer Screening Options
Phase NA Completed
2,004 enrolled 8 charts
DA-CRC
Phase NA Completed
248 enrolled
NEFOPAM
Phase NA Completed
80 enrolled
QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA
Phase 1/2 Completed
43 enrolled 15 charts
High-flow Nasal Cannula Oxygenation in Sedated Endoscopy for High-risk Obstructive Sleep Apnea Patients
Phase NA Completed
80 enrolled
Evaluation the of Role of Vitamin D Supplement on Tumor Response, Inflammation and Apoptosis in Patients With Stage II or III Colorectal Cancer Receiving Chemotherapy.
Phase 4 Completed
44 enrolled
IROCAS
Phase 3 Completed
792 enrolled
IMPACTT
Phase NA Completed
274 enrolled
AYAConnect
Phase NA Completed
63 enrolled
ARFIM
Phase NA Completed
20 enrolled 2 charts
CALM: Managing Distress in Malignant Brain Cancer
Phase NA Completed
60 enrolled
Enhancing Cancer Prevention and Control Pathways-Native Health Initiative
Phase NA Completed
508 enrolled 8 charts
RIFIONA
Phase 3 Completed
320 enrolled
Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer
Phase 1/2 Completed
48 enrolled 16 charts
Compare Preperitoneal Analgesia to Epidural Analgesia for Pain Control After Colon and Rectal Surgery
Phase NA Completed
98 enrolled 20 charts
AVR-CHEMO
Phase NA Completed
150 enrolled
FIDURA
Phase 3 Completed
354 enrolled
ACE
Phase 2 Completed
170 enrolled
AMPLIFY-201
Phase 1 Completed
25 enrolled 15 charts
GLIMMER-01
Phase 1/2 Completed
69 enrolled 13 charts
OPMICS
Phase 4 Completed
360 enrolled
EORTC1616
Phase 2 Completed
1 enrolled
DeFianCe
Phase 2 Completed
188 enrolled
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Phase 1 Completed
23 enrolled
Pharmaceutical Care for Patients Using Capecitabine
Phase NA Completed
176 enrolled
Glucagon Use in Colonoscopies
Phase 4 Completed
100 enrolled 6 charts
PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
Phase 2 Completed
56 enrolled 13 charts
ISCAPE
Phase NA Completed
108 enrolled
COMPANION-003
Phase 2 Completed
49 enrolled
Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer
Phase 2 Completed
123 enrolled 21 charts
Neoadjuvant Therapy for Locally Advanced Colon Cancer
Phase 2 Completed
64 enrolled 11 charts